Paper33430880
Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies.
Wang S and 11 others. Mol Cancer, 2021. Cited by 256 papers, by iCite.
Cite this record
ConductScience Library. Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies. Papers, record 33430880. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33430880
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Body Fluids | Major topic |
| Liquid Biopsy | Major topic |
| RNA, Circular | Major topic |
| Databases, Genetic | |
| Humans | |
| Models, Biological |
Source PubMed
References99
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31625175 | Exosome circ_0044516 promotes prostate cancer cell proliferation and metastasis as a potential biomarker. | J Cell Biochem | 2020 | https://conductscience.org/library/papers/31625175 | PubMed |
| 2 | 29307994 | Circular RNA circ-LDLRAD3 as a biomarker in diagnosis of pancreatic cancer. | World J Gastroenterol | 2017 | https://conductscience.org/library/papers/29307994 | PubMed |
| 3 | 32050790 | CircRNA hsa_circ_0004771 promotes esophageal squamous cell cancer progression via miR-339-5p/CDC25A axis. | Epigenomics | 2020 | https://conductscience.org/library/papers/32050790 | PubMed |
| 4 | 27510448 | CircRNA-protein complexes: IMP3 protein component defines subfamily of circRNPs. | Sci Rep | 2016 | https://conductscience.org/library/papers/27510448 | PubMed |
| 5 | 30674324 | Circular RNA profiling and its potential for esophageal squamous cell cancer diagnosis and prognosis. | Mol Cancer | 2019 | https://conductscience.org/library/papers/30674324 | PubMed |
| 6 | 23446348 | Circular RNAs are a large class of animal RNAs with regulatory potency. | Nature | 2013 | https://conductscience.org/library/papers/23446348 | PubMed |
| 7 | 30429198 | FLI1 Exonic Circular RNAs as a Novel Oncogenic Driver to Promote Tumor Metastasis in Small Cell Lung Cancer. | Clin Cancer Res | 2019 | https://conductscience.org/library/papers/30429198 | PubMed |
| 8 | 29066904 | Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring. | Ther Clin Risk Manag | 2017 | https://conductscience.org/library/papers/29066904 | PubMed |
| 9 | 29421663 | Hsa_circ_0001649: A circular RNA and potential novel biomarker for colorectal cancer. | Biochem Biophys Res Commun | 2018 | https://conductscience.org/library/papers/29421663 | PubMed |
| 10 | 31654054 | Exosomal circRNAs: new players in the field of cholangiocarcinoma. | Clin Sci (Lond) | 2019 | https://conductscience.org/library/papers/31654054 | PubMed |
| 11 | 25746834 | Regulation of circRNA biogenesis. | RNA Biol | 2015 | https://conductscience.org/library/papers/25746834 | PubMed |
| 12 | 32009804 | Utility Of Plasma circBNC2 As A Diagnostic Biomarker In Epithelial Ovarian Cancer. | Onco Targets Ther | 2019 | https://conductscience.org/library/papers/32009804 | PubMed |
| 13 | 30123094 | Circ-ZEB1.33 promotes the proliferation of human HCC by sponging miR-200a-3p and upregulating CDK6. | Cancer Cell Int | 2018 | https://conductscience.org/library/papers/30123094 | PubMed |
| 14 | 25242144 | circRNA biogenesis competes with pre-mRNA splicing. | Mol Cell | 2014 | https://conductscience.org/library/papers/25242144 | PubMed |
| 15 | 25664725 | Exon-intron circular RNAs regulate transcription in the nucleus. | Nat Struct Mol Biol | 2015 | https://conductscience.org/library/papers/25664725 | PubMed |
| 16 | 29911069 | Circular RNAs in Cancer - Lessons Learned From microRNAs. | Front Oncol | 2018 | https://conductscience.org/library/papers/29911069 | PubMed |
| 17 | 30120213 | Global microarray profiling identified hsa_circ_0064428 as a potential immune-associated prognosis biomarker for hepatocellular carcinoma. | J Med Genet | 2019 | https://conductscience.org/library/papers/30120213 | PubMed |
| 18 | 30889786 | Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors: Implications in the Precision Oncology. | J Clin Med | 2019 | https://conductscience.org/library/papers/30889786 | PubMed |
| 19 | 31134126 | Circular RNAs and RNA Splice Variants as Biomarkers for Prognosis and Therapeutic Response in the Liquid Biopsies of Lung Cancer Patients. | Front Genet | 2019 | https://conductscience.org/library/papers/31134126 | PubMed |
| 20 | 30236141 | Circular RNA F-circEA-2a derived from EML4-ALK fusion gene promotes cell migration and invasion in non-small cell lung cancer. | Mol Cancer | 2018 | https://conductscience.org/library/papers/30236141 | PubMed |
Cited by205
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 256 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42794955 | Circular RNAs in NSCLC: Their Role in Tumorigenesis, Tumor Microenvironment Reshaping, and Response to Therapies. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42794955 | PubMed |
| 42631721 | Exploring the Clinical Transformation of circRNA as a Biomarker in Breast Cancer. | Cancer Control | 2026 | https://conductscience.org/library/papers/42631721 | PubMed |
| 42550322 | Circ_0001495 promotes bladder cancer progression by regulating miR-1184 via MAPK signaling pathway. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42550322 | PubMed |
| 42415096 | Circular RNA dynamics in breast-to-brain metastatic cascade. | BMC Biol | 2026 | https://conductscience.org/library/papers/42415096 | PubMed |
| 42313297 | An overview of circular RNAs in the regulation of autophagy in lung cancer. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42313297 | PubMed |
| 42138196 | CircRAD18 promotes glioblastoma proliferation, migration and invasion via the miR‑1231/LUC7L2 axis. | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42138196 | PubMed |
| 42109528 | The "cutting edge" of non-canonical RNA splicing. | Front Mol Biosci | 2026 | https://conductscience.org/library/papers/42109528 | PubMed |
| 42057369 | Circular RNAs in Oral Squamous Cell Carcinoma: A Systematic Review of Emerging Diagnostic and Prognostic Biomarkers. | Eur J Dent | 2026 | https://conductscience.org/library/papers/42057369 | PubMed |
| 41908224 | Evaluation of the circular RNA Pum1_0014, miRNA-146a, and miRNA-141-3p as biomarkers in PCOS. | J Taibah Univ Med Sci | 2026 | https://conductscience.org/library/papers/41908224 | PubMed |
| 41824177 | The early diagnostic value of lung cancer autoantibodies and tumor markers in lung cancer. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/41824177 | PubMed |
| 41741417 | Circular RNAs in metabolic health: bridging the gap between molecular biology and therapy. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41741417 | PubMed |
| 41514444 | Unlocking the power of non-coding RNAs: toward real-time cancer monitoring in precision oncology. | Mol Cancer | 2026 | https://conductscience.org/library/papers/41514444 | PubMed |
| 41501162 | Mechanism study of circCCDC134 regulating the biological behaviors of PDGF-BB-induced oral mucosal fibroblast. | Sci Rep | 2026 | https://conductscience.org/library/papers/41501162 | PubMed |
| 41416448 | Exosomal circRNAs in hepatocellular carcinoma: Implications for the development and therapeutic resistance of hepatocellular carcinoma (Review). | Int J Oncol | 2026 | https://conductscience.org/library/papers/41416448 | PubMed |
| 41281941 | Circular RNA-based liquid biopsy: a promising approach for monitoring drug resistance in cancer. | Cancer Drug Resist | 2025 | https://conductscience.org/library/papers/41281941 | PubMed |
| 41175216 | Advancing precision medicine with bioelectroanalytical technologies leveraging unconventional nucleic acid forms. | Anal Bioanal Chem | 2026 | https://conductscience.org/library/papers/41175216 | PubMed |
| 41168410 | HypoxamiRs in pancreatic cancer: master regulators of the hypoxic tumor microenvironment. | Cell Biol Toxicol | 2025 | https://conductscience.org/library/papers/41168410 | PubMed |
| 41029680 | Extracellular vesicles for targeted drug delivery: advances in surface modification strategies and therapeutic applications. | J Transl Med | 2025 | https://conductscience.org/library/papers/41029680 | PubMed |
| 40986199 | Emerging roles and therapeutic potential of non-coding RNA in osteosarcoma: a review. | Med Oncol | 2025 | https://conductscience.org/library/papers/40986199 | PubMed |
| 40936715 | Peripheral blood TCR repertoire improves early detection across multiple cancer types utilizing a cancer predictor. | Front Oncol | 2025 | https://conductscience.org/library/papers/40936715 | PubMed |
Genes29
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33430880
GET https://conductscience.org/api/papers/v1/33430880/references?page=2